In busy year with Haleon spinoff and Zantac lawsuits, GSK CEO Emma Walmsley scored slight pay raise

For her efforts in leading British pharma giant GSK through a transformational year, the company's CEO Emma Walmsley nabbed a slight pay raise last year.

Walmsley collected 8.45 million pound sterling ($10.17 million) in 2022, a 3% increase from the prior year, according to GSK's annual report (PDF).